JAK2 V617 ALLELE BURDEN AND THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

被引:0
|
作者
Kalagiakou, E.
Evmorfiadis, I. [1 ]
Hatzouli, M. [1 ]
Manioudaki, E. [1 ,2 ]
Kotsopoulou, M. [2 ]
Malegkou, S. [3 ]
Vallianatou, K. [1 ]
Triantafyllopoulou, I. -D. [2 ]
Samaridis, E. [1 ]
Dadiotis, L. [3 ]
Mitsouli, Ch. [2 ]
Belessi, C. [1 ]
Laoutaris, N. [1 ]
机构
[1] Nikea Gen Hosp, Dept Haematol, Athens, Greece
[2] Metaxa Oncol Hosp, Haematol Clin, Athens, Greece
[3] Tzan Gen Hosp, Transfus Ctr, Piraeus, Greece
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0050
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [31] JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia
    Randi, Maria Luigia
    Ruzzon, Elisabetta
    Tezza, Fabiana
    Scapin, Margherita
    Duner, Elena
    Scandellari, Raffaella
    Fabris, Fabrizio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 23 (01) : 17 - 21
  • [32] Clinical Features and Outcomes of Polycythemia Vera Patients with Different JAK2 V617F Mutational Status and Allele Burden
    Zhang, Lan
    Jin, Keyi
    Yang, Min
    Zhu, Xiaoqiong
    Huang, Jian
    BLOOD, 2022, 140 : 12286 - 12287
  • [33] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study
    Vannucchi, Alessandro Maria
    Verstovsek, Srdan
    Guglielmelli, Paola
    Griesshammer, Martin
    Burn, Timothy C.
    Naim, Ahmad
    Paranagama, Dilan
    Marker, Mahtab
    Gadbaw, Brian
    Kiladjian, Jean-Jacques
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1113 - 1120
  • [34] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study
    Alessandro Maria Vannucchi
    Srdan Verstovsek
    Paola Guglielmelli
    Martin Griesshammer
    Timothy C. Burn
    Ahmad Naim
    Dilan Paranagama
    Mahtab Marker
    Brian Gadbaw
    Jean-Jacques Kiladjian
    Annals of Hematology, 2017, 96 : 1113 - 1120
  • [35] Observation of a higher JAK2 V617F homozygous mutated clone in polycythemia vera compared to essential thrombocythemia
    Liu H.
    Tong C.
    Cai P.
    Gu J.
    Lin Y.
    Zhang Y.
    Teng W.
    Wang H.
    Zhu P.
    Frontiers of Medicine in China, 2008, 2 (3): : 309 - 313
  • [36] JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum
    Rumi, Elisa
    Pietra, Daniela
    Elena, Chiara
    Casetti, Ilaria
    Antonio, Emanuela Sant
    Astori, Cesare
    Milanesi, Chiara
    Bellini, Marta
    Boveri, Emanuela
    Ferretti, Virginia
    Pascutto, Cristiana
    Cazzola, Mario
    BLOOD, 2013, 122 (21)
  • [37] JAK2 Haplotype SNP Analysis in Essential Thrombocythemia: Clinical and JAK2V617F Allele Burden Correlates in 226 Patients
    Pardanani, Animesh D.
    Lasho, Terra
    Finke, Christy
    Hussein, Kebede
    Elliott, Michelle
    Tefferi, Ayalew
    BLOOD, 2009, 114 (22) : 1130 - 1130
  • [38] Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients
    Besses, Carlos
    Alvarez-Larran, Alberto
    Martinez-Aviles, Luz
    Mojal, Sergi
    Longaron, Raquel
    Salar, Antonio
    Florensa, Lourdes
    Serrano, Sergi
    Bellosillo, Beatriz
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (04) : 413 - 419
  • [39] Tissue factor activity is increased in neutrophils from JAK2 V617F-mutated essential thrombocythemia and polycythemia vera patients
    Reeves, Brandi N.
    Kim, Soo Jin
    Song, Jihyun
    Wilson, Kathryn J.
    Henderson, Michael W.
    Key, Nigel S.
    Pawlinski, Rafal
    Prchal, Josef T.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (02) : E37 - E40
  • [40] Hydroxyurea dose impacts hematologic parameters In polycythemia vera and essential thrombocythemia but does not appreciably affect JAK2-V617F allele burden
    Zalcberg, Ilana Renault
    Ayres-Silva, Jackme
    de Azevedo, Alexandre Mello
    Solza, Cristiana
    Daumas, Adelmo
    Bonamino, Martin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03):